|

Inhaled Treprostinil (Tyvaso Nebulizer) Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Bastiaan Driehuys1

Indications

  • Hypoxemia1
  • COPD - Chronic Obstructive Pulmonary Disease1
  • COPD1

Durham, North Carolina1 trial

Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia

Duke Asthma Allergy and Airway Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.